# ClariPI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/claripi

- Industry: Medical Devices & Equipment
- Headquarters: Seoul, South Korea
- Website: www.claripi.com/
- Total disclosed funding: $2.6M
- Latest round: Series A (Mar 26, 2021)
- Investors on record: 1

## About

Based in Seoul, South Korea, ClariPi Inc. was founded in February 2015 by Seoul National University Convergence Science and Technology University Professor Jong-hyo Kim and medical business expert Hyun-sook Park to provide innovative solutions for the unmet needs in medical imaging fields through the convergence of intelligent big data computing and medical imaging technologies. In 2016, ClariPi Inc. established a sinogram synthesis-based-ultra-low dose CT simulation platform and created a database for paired standard and ultra-low-dose CT image. From 2017 to 2020, ClariPi Inc. began the use and pursued the development of AI-powered CT denoising solution product, ClariCT.AI. This product was shown in several showcase opportunities in the Middle East and export in Europe. In September 2025, ClariPI Inc. raised KRW 12.6 billion in pre-IPO funding led by new investor Samho Green Investment with participation from other unspecified investors.

The company provides AI-powered medical imaging products namely; Ultra-Low-Dose AI-Powered CT Image 
Denoising Solution (ClariCT.AI), ClariPulmo, CalriSigmam and ClariAdipo.

The company will use the 2025 funding to speed up its international market expansion.

## Funding rounds

- Series A, Mar 26, 2021, $2.6M — Korea Investment Partners

## Investors

- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series A